Cargando…
Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
BACKGROUND: Today, heart failure is one of the leading causes of death and disability in most developed and developing countries. By 2030, more than 23.3 million people are projected to die of cardiovascular diseases each year, and the prevalence of heart failure is expected to increase by 25%. One...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476319/ https://www.ncbi.nlm.nih.gov/pubmed/37665450 http://dx.doi.org/10.1186/s13561-023-00457-4 |